Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centrul De HematologiefiledCriticalCentrul De Hematologie
Priority to RO109251ApriorityCriticalpatent/RO85245B1/ro
Publication of RO85245A2publicationCriticalpatent/RO85245A2/fr
Publication of RO85245B1publicationCriticalpatent/RO85245B1/ro
The lymphocyte response to primary Moloney sarcoma virus tumors in BALB/c mice: definition of the active subpopulations at different times after infection
A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction
Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type 1
Procédé pour la séparation et l'isolement de la fraction AHF (facteur antihémophilique), la fraction fibronectine et la fraction Von Willebrand's ristocétine cofacteur à partir du plasma sanguin
Persistent in vitro infection by human T‐cell leukemia‐lymphoma virus (HTLV) of normal human T‐lymphocytes from blood relatives of patients with HTLV‐associated mature T‐cell neoplasms
Frequent coexpression of cytolytic activity and lymphokine production among human T lymphocytes. Production of B cell growth factor and interleukin 2 by T8+ and T4+ cytolytic clones